Part 1: Epidemiology, Risk Factors, Diagnosis and Prognosis

The session is dedicated to three topics of interest to broad clinical hepatology practice. Attendees will learn about the latest updates and practical approaches to common clinical scenarios encountered in daily practice by experts in the disease state.

In this session, hepatology trainees and practicing hepatologists will tackle a controversial hepatology topic in a lively debate format. Debaters and audience members will grapple with opposing scientific, societal, individual, and financial viewpoints i

Part 2: Endoscopic Management in Cirrhotics and PRE-Transplant candidates

Attendees will hear a critical discussion, with HEPATOLOGY Associate Editors Yujin Hoshida, Kari Nejak-Bowen and Harmeet Malhi, on the most cutting-edge, game changing scientific advances that were published in HEPATOLOGY and other journals over the past

Journals over the past year, will be discussed by HEPATOLOGY Associate Editors Jacqueline O'Leary, Cynthia Levy and Sumera Ilyas. Then, Editor-in-Chief Gregory Gores and Associate Editor Juan Abraldes will host a panel discussion that highlights the clini

(1 of 2 identical workshops offered during TLM 2023)

Individuals with Hepatitis C virus are curable if they follow a simplified treatment algorithm of highly effective, short-duration direct-acting antiviral therapy. Nevertheless, less than half of people living with hepatitis C have been diagnosed and only

The goal of this session is to review current innovations in transplantation and what is being developed for use in the near future. The session will focus on the innovations in artificial organs and xenotransplantation, future policy changes in organ all

Part 2: Multidisciplinary and Critical Care Management of ACLF